USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Active Pharmaceutical Ingredient Market By Type (Innovative APIs, and Generic APIS), By Manufacturer (Captive Manufacturers, and Merchant Manufacturers), By Type of Synthesis (Synthetic, and Biotech), By Drug Type (Prescription Drugs, and Over-the-counter Drugs), and By Therapeutic Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain management, Respiratory Diseases, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026


Global Active Pharmaceutical Ingredient Market Size, Share

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

[225+ Pages Report] Global Active Pharmaceutical Ingredient market was valued at USD 177.6 billion in 2019, which is anticipated to hit USD 258.3 billion by 2026 with an expected CAGR of 5.5% between 2020 and 2026.

logoMarket Overview

API is synthetically and organically complex components of medicines with a clear effect on disease cure, moderation, therapy, and counter activity. Over the past few decades, the worldwide API industry has seen tremendous growth due to the increased use of drugs and biologics in disease management. The increasing appropriation of value models for API production, such as Good Manufacturing Practices (GMP), existing GMPs (cGMP) has improved the safety guidelines. On the other hand, the API sector faces the challenges of, for example, shortening the improvement process, reducing the cost of progress, strengthening the procedural framework, and complying with consistency guidelines without taking advantage of them.

logoIndustry Growth Factor

The growing activity for research and development on drug production increased popularity of generic products, and the use of biopharmaceuticals, are the key factors driving the growth of the global active pharmaceutical industry. The unfavorable policies of price regulation for drugs in different countries and high production costs are, however, likely to hamper demand growth.

The growing prevalence of chronic diseases would raise the demand for medicines, which is projected to accelerate the market growth of active pharmaceutical ingredients in the immediate future. The world's leading cause of death was cardiovascular diseases, estimating about 17.9 million lives a year, according to the WHO.

Around 5.8 million people in the U.S. were reported to suffer from Alzheimer's in 2018 by the Alzheimer's Association. The illness is the sixth most common cause of death for people over 65 years of age in the United States. The population of baby booms is estimated to reach 14 million and to intensify in the projected timeframe, approaching the age of about 65. By 2050, every 33 seconds a new case of this disease could arise. ?

In addition, the sales, acquisitions, cooperation, and international expansions of new drugs and biological products are some of the competitive market stabilization measures. In the near term, this will contribute to demand growth. In 2020, for example, and Bright Path Laboratories worked together to create AI-based technologies to produce vital APIs, which are expected to produce essential small molecular medicines.

Drugs such as anti-infective and diabetes, cardiovascular, analgesics, and pain relief medicines historically occupied the Active Pharmaceutical Ingredients (API) industry. However, the market for complex APIs used in new formulations, targeting niche clinical areas, is changing according to R&D patterns.

Active Pharmaceutical Ingredient Market

logoActive Pharmaceutical Ingredient Market: COVID-19 Impact

The COVID-19 pandemic in 2020 produced a positive market effect, as the countries and key players produce large volumes of ingredients to keep demands for COVID 19 medication. COVID-19 has resulted in pharmaceutical companies reorienting their models to a wider population of customers. For instance, the US has requested that coronavirus treatments be imported from India for hydroxychloroquine (HCQ). The virus has already interrupted Canada's supply chain and may cause patients in the country problems. Canadian pharmaceutical supervisors are expanding their services to new areas of countries other than China.

logoGlobal Active Pharmaceutical Ingredient Market: Regional Analysis

In 2020, North America was the biggest market share of 39.5% and its lead over the projected horizon is anticipated to continue. This is due to the increased cancer epidemiology, as well as other lifestyle disorders, and hence encourages research and development programs to fuel business growth.

In the forecast timeframe, Asia Pacific is expected to show the fastest CAGR. The area is benefitted from the existence of economies such as China and India, on which the world depends on low-cost API processing. The region is expected to improve demand growth by rising healthcare spending.

Over the projected period, Europe is expected to see considerable growth. There is an expectation that increased research spending and the local involvement of major industry players in the area would propel the market. As a result of increased funding, the number of biopharmaceutical companies in Europe is rising.

logoGlobal Active Pharmaceutical Ingredient Market: Competitive Players

There are great complexities in the market of active pharmaceutical ingredients. Blockbuster drugs are likely to continue to compete highly over the projected timeframe, owing to the expiry of the patent, rising outsourcing practices due to high manufacturing costs, and strict production regulations for APIs.

Many key figures are subject to legal investigation due to non-compliance. For example, in August 2019, the United States FDA released 75 API manufacturing plants alarm letters, half of whom were for Indian and Chinese companies. Such rigorous legislation can serve as a limiting factor in the development of the industry. Furthermore, the development of new API facilities is slowing down legal problems. For eg, the U.S.FDA faced problems with the API plants of Dr. Reddy Laboratories and Eli Lilly and the company in 2020.

Some prominent players in the global active pharmaceutical ingredients market are Cipla, Bristol Myers Squibb, Boehringer Ingelheim GmbH, BASF SE, Aurobindo Pharma, Albemarle Corporation, Abbvie Inc., Dr. Reddy’s Laboratories Ltd, Eli Lilly and Company, Viatris Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc., Novartis AG, Mylan NV, Merck & Co., and Lupin Ltd among others.

logoGlobal Active Pharmaceutical Ingredient Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • The Middle East and Africa


Active Pharmaceutical Ingredient Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Cipla
  • Bristol Myers Squibb
  • Boehringer Ingelheim GmbH
  • Aurobindo Pharma
  • Albemarle Corporation
  • Abbvie Inc.
  • Dr. Reddy’s Laboratories Ltd
  • Eli Lilly and Company
  • Viatris Inc
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Pfizer Inc.
  • Novartis AG
  • Mylan NV
  • Merck & Co.
  • Lupin Ltd 

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Active Pharmaceutical Ingredient Market.
According to Facts and Factors research report, the global Active Pharmaceutical Ingredient Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Active Pharmaceutical Ingredient Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Active Pharmaceutical Ingredient Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Active Pharmaceutical Ingredient Market in North America over coming decade.
why choose fnf
key questions answers

Related Reports

report img

Pharmacovigilance and Drug Safety Software Market Report 2021 – 2026

[187+ Pages Report] According to the latest report titled Global Pharmacovigilance and Drug Safety Software Market published by Facts Factors, the study offers a detailed and comprehensive read. The global pharmacovigilance and drug safety software market witnessed a significant market value of U...

Published Date : 02-Nov-2021 | | Category : | Pages : 187 | Format : Read more

Inquiry for Buying Request Sample
report img

Biohacking Market Report , 2021 – 2026

[197+ Pages Report] The latest report published by Facts Factors titled global biohacking markethas a global perspective on the latter coupled with the market size, volume, drivers, and restraints to name a few. We estimate that the biohacking market will hold a value of USD 14.65 Billion in the ...

Published Date : 06-Aug-2021 | | Category : | Pages : 197 | Format : Read more

Inquiry for Buying Request Sample